Revenue: The sum of all revenue fields included for a company's operating activities.
Silence Therapeutics PLC Sponsored ADR (SLN) had Revenue of $0.22M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$0.22M |
$-27.35M |
|
$0.09M |
|
$0.14M |
|
$24.19M |
|
$-23.96M |
|
$-3.38M |
|
$-27.34M |
|
$-27.34M |
|
$-27.35M |
|
$-27.35M |
|
$-27.35M |
|
$-27.35M |
|
$-23.96M |
|
$-23.82M |
|
141.70M |
|
141.70M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$148.55M |
|
$1.77M |
|
$16.68M |
|
$165.23M |
|
$14.77M |
|
-- |
|
$56.31M |
|
$71.08M |
|
$94.16M |
|
$83.22M |
|
$94.16M |
|
141.70M |
|
| Cash Flow Statement Financials | |
$-34.09M |
|
$-45.94M |
|
$0.01M |
|
$121.33M |
|
$41.74M |
|
$-79.59M |
|
$5.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
62.05% |
|
-10697.77% |
|
-10697.77% |
|
-- |
|
-12207.14% |
|
-12211.61% |
|
$-34.15M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
8052.59 |
|
-29.05% |
|
-32.87% |
|
-16.55% |
|
-29.05% |
|
$0.66 |
|
$-0.24 |
|
$-0.24 |
|